Shenal Thalgahagoda
Shenal Thalgahagoda has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Umeshi Ishanthika Karunadasa
University of Peradeniya, Postgraduate Institute of Science, University of Peradeniya
3 shared publications - Niranjalee Samanthika Egodawaththe
Teaching Hospital Peradeniya
2 shared publications - Shamali Abeyagunawardena
Faculty of Medicine, University of Peradeniya, Peradeniya, Sri Lanka
2 shared publications A. S. Abeyagunawardena
Department of Paediatrics, Faculty of Medicine, University of Peradeniya, Peradeniya, Sri Lanka
1 shared publication- Andra Hennadige Heshan Malinga Jayaweera
Sri Lanka College of Paediatricians, Colombo, Sri Lanka
1 shared publication - Anuradha Bogahapitiya
Teaching Hospital, Peradeniya, Sri Lanka
1 shared publication
Latest Publications
- 9 February 2023
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 182 (4) , 1741-1747
Single vs split dose of prednisolone in the treatment of relapses of childhood nephrotic syndrome
Nephrotic syndrome is the commonest glomerular disease in childhood. It usually follows a relapsing and remitting course. Corticosteroids are the mainstay of treatment for both the first episode and subsequent relapses. This study was conducted at a single centre to compare the clinical response to a single dose vs. split dose of prednisolone in the treatment of relapses of childhood nephrotic syndrome. Children between the ages of 1 and 14 years admitted with a relapse of idiopathic steroid sensitive nephrotic syndrome from August 2019 to February 2020 were considered for recruitment. A block randomization method based on age was used for allocation. Patients randomised to group A received oral prednisolone at 60 mg/m2 as a single morning dose, while those randomised to group B received the same total dose as two divided doses, of which 2/3 was given in the morning and the rest in the evening. Treatment was continued until remission was achieved following which all patients were switched to alternate day prednisolone. An independent sample t test was used to compare the two groups. One hundred and four episodes of relapse occurring in 96 children were included of which 49 were treated with prednisolone as a split dose and 55 were treated with a single dose of prednisolone. The mean duration to achieve remission for the split-dose group was 8.02 days (SD 1.58) while it was 9.74 days (SD 3.72) for the single-dose group. This difference was statistically highly significant (t(102) = 3.004; p = 0.001; CI 0.58 to 2.86). There was no difference in the adverse events profile of the two groups. Conclusion: The use of prednisolone as a split dose results in a shorter duration to achieve remission when compared to a single morning dose, resulting in a lower cumulative dose of prednisolone to achieve remission. What is Known: • Corticosteroids are the mainstay of treatment for childhood nephrotic syndrome. • Corticosteroids are given as a single dose in the morning to minimise adrenocortical suppression. What is New: • A more rapid attainment of remission can be achieved with a split dose of corticosteroids.
- 9 February 2023
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 182 (4) , 1741-1747
Single vs split dose of prednisolone in the treatment of relapses of childhood nephrotic syndrome
Nephrotic syndrome is the commonest glomerular disease in childhood. It usually follows a relapsing and remitting course. Corticosteroids are the mainstay of treatment for both the first episode and subsequent relapses. This study was conducted at a single centre to compare the clinical response to a single dose vs. split dose of prednisolone in the treatment of relapses of childhood nephrotic syndrome. Children between the ages of 1 and 14 years admitted with a relapse of idiopathic steroid sensitive nephrotic syndrome from August 2019 to February 2020 were considered for recruitment. A block randomization method based on age was used for allocation. Patients randomised to group A received oral prednisolone at 60 mg/m2 as a single morning dose, while those randomised to group B received the same total dose as two divided doses, of which 2/3 was given in the morning and the rest in the evening. Treatment was continued until remission was achieved following which all patients were switched to alternate day prednisolone. An independent sample t test was used to compare the two groups. One hundred and four episodes of relapse occurring in 96 children were included of which 49 were treated with prednisolone as a split dose and 55 were treated with a single dose of prednisolone. The mean duration to achieve remission for the split-dose group was 8.02 days (SD 1.58) while it was 9.74 days (SD 3.72) for the single-dose group. This difference was statistically highly significant (t(102) = 3.004; p = 0.001; CI 0.58 to 2.86). There was no difference in the adverse events profile of the two groups. Conclusion: The use of prednisolone as a split dose results in a shorter duration to achieve remission when compared to a single morning dose, resulting in a lower cumulative dose of prednisolone to achieve remission. What is Known: • Corticosteroids are the mainstay of treatment for childhood nephrotic syndrome. • Corticosteroids are given as a single dose in the morning to minimise adrenocortical suppression. What is New: • A more rapid attainment of remission can be achieved with a split dose of corticosteroids.
- Open Access
- 5 March 2022
- Published by Sri Lanka Journals Online in Sri Lanka Journal of Child Health
- Vol. 51 (1) , 75-83
Causative agents and their antimicrobial sensitivities in hospitalised children with recurrent urinary tract infections: Experience in a paediatric nephrology unit
Introduction: Urinary tract infection (UTI) has a significant morbidity highlighting the importance of preventing recurrences. Knowledge on aetiological agents and their antibiotic sensitivities is crucial for proper management of affected children.Objectives: To determine the causative microorganisms and their antibiotic sensitivity pattern in patients with recurrent UTIs on uroprophylaxis and to compare the first episode of UTI with recurrent UTIs regarding causative organisms and antibiotic sensitivity.Method: A descriptive study was done at Teaching Hospital Peradeniya, recruiting children aged 1 month to 14 years, admitted from 1st May 2019 to 30th April 2020 with breakthrough febrile or symptomatic UTIs after being on antibiotic prophylaxis. Details were collected using a validated and pre-tested questionnaire.Results: A total of 141 UTIs of 52 children were analysed. There were 31 (59.6%) boys; 76.3% episodes were febrile and 22.7% were afebrile but symptomatic UTIs. Micturating cystourethrogram revealed that 29 (56%) children had vesico-ureteric reflux; renal scarring was noted in the majority; 24 (46.1%) children had bladder and bowel dysfunction. Constipation was found in 29 (55.7%). Main pathogens implicated in recurrent UTIs were Escherichia coli (E coli) (55%), Klebsiella species (14.6%) and Pseudomonas aeruginosa (13.5%). First episodes were caused by E coli (57.7%), Klebsiella species (17.3%) and Proteus mirabilis (11.5%). Imipenem (89.8%), amikacin (87.7%) and ciprofloxacin (87.7%) were the most sensitive antibiotics for E coli. Sensitivity of E colito cotrimoxazole was significantly decreased during recurrent episodes (p=0.025). More than 2 UTIs were significantly associated with age above 24 months, female gender, constipation, bladder bowel dysfunction (BBD) and renal scarring.Conclusions: Primary and recurrent UTIs in children were mainly caused by E coli. Antibiotic sensitivity rates of E. coli were comparatively lower in recurrent UTIs. Age above 24 months, female gender, constipation, BBD and renal scarring showed a significant association with multiple UTI recurrences.Sri Lanka Journal of Child Health, 2022; 51(1): 75-83
- 5 March 2022
- Published by Sri Lanka Journals Online in Sri Lanka Journal of Child Health
- Vol. 51 (1) , 75-83
Open AccessCausative agents and their antimicrobial sensitivities in hospitalised children with recurrent urinary tract infections: Experience in a paediatric nephrology unit
Introduction: Urinary tract infection (UTI) has a significant morbidity highlighting the importance of preventing recurrences. Knowledge on aetiological agents and their antibiotic sensitivities is crucial for proper management of affected children.Objectives: To determine the causative microorganisms and their antibiotic sensitivity pattern in patients with recurrent UTIs on uroprophylaxis and to compare the first episode of UTI with recurrent UTIs regarding causative organisms and antibiotic sensitivity.Method: A descriptive study was done at Teaching Hospital Peradeniya, recruiting children aged 1 month to 14 years, admitted from 1st May 2019 to 30th April 2020 with breakthrough febrile or symptomatic UTIs after being on antibiotic prophylaxis. Details were collected using a validated and pre-tested questionnaire.Results: A total of 141 UTIs of 52 children were analysed. There were 31 (59.6%) boys; 76.3% episodes were febrile and 22.7% were afebrile but symptomatic UTIs. Micturating cystourethrogram revealed that 29 (56%) children had vesico-ureteric reflux; renal scarring was noted in the majority; 24 (46.1%) children had bladder and bowel dysfunction. Constipation was found in 29 (55.7%). Main pathogens implicated in recurrent UTIs were Escherichia coli (E coli) (55%), Klebsiella species (14.6%) and Pseudomonas aeruginosa (13.5%). First episodes were caused by E coli (57.7%), Klebsiella species (17.3%) and Proteus mirabilis (11.5%). Imipenem (89.8%), amikacin (87.7%) and ciprofloxacin (87.7%) were the most sensitive antibiotics for E coli. Sensitivity of E colito cotrimoxazole was significantly decreased during recurrent episodes (p=0.025). More than 2 UTIs were significantly associated with age above 24 months, female gender, constipation, bladder bowel dysfunction (BBD) and renal scarring.Conclusions: Primary and recurrent UTIs in children were mainly caused by E coli. Antibiotic sensitivity rates of E. coli were comparatively lower in recurrent UTIs. Age above 24 months, female gender, constipation, BBD and renal scarring showed a significant association with multiple UTI recurrences.Sri Lanka Journal of Child Health, 2022; 51(1): 75-83
- Open Access
- 4 September 2021
- Published by Sri Lanka Journals Online in Sri Lanka Journal of Child Health
- Vol. 50 (3) , 535-538
A case of systemic envenomation by hump-nosed viper associated with coagulopathy, haemolytic uraemic syndrome and acute hepatic injury
- 4 September 2021
- Published by Sri Lanka Journals Online in Sri Lanka Journal of Child Health
- Vol. 50 (3) , 535-538
Open AccessA case of systemic envenomation by hump-nosed viper associated with coagulopathy, haemolytic uraemic syndrome and acute hepatic injury
- Open Access
- 15 December 2020
- Published by Sri Lanka Journals Online in Sri Lanka Journal of Medicine
- Vol. 29 (2) , 90
Disseminated Cryptosporidium Parvum infection in a post renal transplant child
- 15 December 2020
- Published by Sri Lanka Journals Online in Sri Lanka Journal of Medicine
- Vol. 29 (2) , 90
Open AccessDisseminated Cryptosporidium Parvum infection in a post renal transplant child
- Open Access
- 5 December 2020
- Published by Sri Lanka Journals Online in Sri Lanka Journal of Child Health
- Vol. 49 (4) , 412-413
Parameningeal embryonal rhabdomyosarcoma presenting as facial nerve palsy in a young girl
Sri Lanka Journal of Child Health, 2020; 49(4): 412-413
- 5 December 2020
- Published by Sri Lanka Journals Online in Sri Lanka Journal of Child Health
- Vol. 49 (4) , 412-413
Open AccessParameningeal embryonal rhabdomyosarcoma presenting as facial nerve palsy in a young girl
Sri Lanka Journal of Child Health, 2020; 49(4): 412-413
- Open Access
- 5 March 2019
- Published by Sri Lanka Journals Online in Sri Lanka Journal of Child Health
- Vol. 48 (1) , 84-87
A possible case of levamisole-induced pauci-immune focal necrotising and crescentic glomerulonephritis
Sri Lanka Journal of Child Health, 2019: 48(1): 84-87
- 5 March 2019
- Published by Sri Lanka Journals Online in Sri Lanka Journal of Child Health
- Vol. 48 (1) , 84-87
Open AccessA possible case of levamisole-induced pauci-immune focal necrotising and crescentic glomerulonephritis
Sri Lanka Journal of Child Health, 2019: 48(1): 84-87
- Open Access
- 5 March 2019
- Published by Sri Lanka Journals Online in Sri Lanka Journal of Child Health
- Vol. 48 (1) , 77-79
Disseminated tuberculosis following immunosuppressive therapy for nephrotic syndrome
Sri Lanka Journal of Child Health, 2019; 48(1): 77-79
- 5 March 2019
- Published by Sri Lanka Journals Online in Sri Lanka Journal of Child Health
- Vol. 48 (1) , 77-79
Open AccessDisseminated tuberculosis following immunosuppressive therapy for nephrotic syndrome
Sri Lanka Journal of Child Health, 2019; 48(1): 77-79
- Open Access
- 5 March 2019
- Published by Sri Lanka Journals Online in Sri Lanka Journal of Child Health
- Vol. 48 (1) , 53-58
Efficacy and side effects of mycophenolate mofetil therapy in children with steroid dependent nephrotic syndrome in a tertiary paediatric nephrology centre in Sri Lanka
Background: Mycophenolate mofetil (MMF) has been shown to be a well-tolerated drug which could maintain prolonged remission in patients with steroid dependent nephrotic syndrome (SDNS). MMF is known to have a steroid sparing effect.Objectives: To determine the effect of MMF in reducing relapses in Sri Lankan children with SDNS and to ascertain the incidence of side effects of MMF in this population.Method: Children between 1-18 years of age with SDNS who had been treated with MMF for 12 months or more at the paediatric nephrology unit, Teaching Hospital Peradeniya, were selected and reviewed retrospectively. Children who had previously received immunosuppressive therapy other than prednisolone, cyclophosphamide, cyclosporin A, tacrolimus and levamisole and those who were on MMF for indications other than idiopathic nephrotic syndrome were excluded. Children and parents were interviewed and their patient-held health records, including their ‘nephrotic syndrome diary’ were reviewed. Data were collected twice a week using pretested questionnaires, in the nephrotic syndrome clinic for a period of 8 weeks. Results were analysed using SPSS version 23.Results:Thirty five children who met the selection criteria were included. Of them 26 (74.3%) were male and 09 (25.7%) were female. The median age was 9.7 years. Mean number of relapses in the year before starting MMF and the year after starting MMF were 3.5 and 1.8 respectively. The reduction in the relapse rate after being on MMF was significant (p=0.009). Child’s age or gender did not impact the relapse rate (p>0.05). The most common side effect observed was cough (20%) and the least common ones were abdominal pain, dyspnoea and dizziness (3%).Conclusions: In this study MMF reduced relapse rates of children with SDNS, despite some minor side effects.
- 5 March 2019
- Published by Sri Lanka Journals Online in Sri Lanka Journal of Child Health
- Vol. 48 (1) , 53-58
Open AccessEfficacy and side effects of mycophenolate mofetil therapy in children with steroid dependent nephrotic syndrome in a tertiary paediatric nephrology centre in Sri Lanka
Background: Mycophenolate mofetil (MMF) has been shown to be a well-tolerated drug which could maintain prolonged remission in patients with steroid dependent nephrotic syndrome (SDNS). MMF is known to have a steroid sparing effect.Objectives: To determine the effect of MMF in reducing relapses in Sri Lankan children with SDNS and to ascertain the incidence of side effects of MMF in this population.Method: Children between 1-18 years of age with SDNS who had been treated with MMF for 12 months or more at the paediatric nephrology unit, Teaching Hospital Peradeniya, were selected and reviewed retrospectively. Children who had previously received immunosuppressive therapy other than prednisolone, cyclophosphamide, cyclosporin A, tacrolimus and levamisole and those who were on MMF for indications other than idiopathic nephrotic syndrome were excluded. Children and parents were interviewed and their patient-held health records, including their ‘nephrotic syndrome diary’ were reviewed. Data were collected twice a week using pretested questionnaires, in the nephrotic syndrome clinic for a period of 8 weeks. Results were analysed using SPSS version 23.Results:Thirty five children who met the selection criteria were included. Of them 26 (74.3%) were male and 09 (25.7%) were female. The median age was 9.7 years. Mean number of relapses in the year before starting MMF and the year after starting MMF were 3.5 and 1.8 respectively. The reduction in the relapse rate after being on MMF was significant (p=0.009). Child’s age or gender did not impact the relapse rate (p>0.05). The most common side effect observed was cough (20%) and the least common ones were abdominal pain, dyspnoea and dizziness (3%).Conclusions: In this study MMF reduced relapse rates of children with SDNS, despite some minor side effects.